Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The transmembrane protein with metallophosphoesterase domain (TMPPE) is an uncharacterized membrane protein predicted to include five transmembrane alpha-helical regions and harbors a metallophosphoesterase domain[3][5]. It is part of a broader group of 5-transmembrane domain proteins, a significant portion of which are involved in localization, membrane trafficking, or transport functions, and some act as enzymes[1]. The metallophosphoesterase domain suggests potential enzymatic activity in hydrolyzing phosphoester bonds, but no direct biochemical, physiological, or therapeutic function has been established for TMPPE itself[1][3]. TMPPE has been noted as not fully characterized, and more research is needed to define its biological role, disease relevance, and druggability[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein with metallophosphoesterase domain (TMPPE).